FDA calls for substantial reform of NCA pay structure
Every year the FDA gives evidence to the National Crime Agency Renumeration Review Body (NCARRB), which makes independent recommendations to the government on the pay and allowances of National Crime Agency (NCA) officers designated with operational powers.
In its evidence to the NCARRB for 2024 the FDA argues for urgent reform of the NCA pay structure. An FDA survey found that members thought it was extremely or very important that the pay system rewarded increased skills, knowledge and experience. However, none of the respondents could currently see a clear link between their pay and their performance in their experience of the current pay arrangements.“Pay in the Agency remains significantly behind Police pay and increasingly is becoming less competitive for senior staff in the wider civil service. The FDA recognises the government imposed constraints that have dictated the NCA approach to pay, our members cannot afford to see their pay fall further behind. It is crucial that the momentum for pay reform is supported by the Treasury with sufficient funding to secure the long-term future of the agency.”
Read the FDA’s full evidence.
Related News
-
Why we need an independent pay review body for delegated grades
Assistant General Secretary Lauren Crowley outlines the FDA’s response to this week’s pay announcements and shares the FDA’s long-term plans for civil service pay.
-
A different approach
With civil service pay largely unchanged for the last 30 years, Dave Penman outlines why the next government should make long-term reform an early priority.
-
FDA calls for substantial reform of NCA pay structure
In its evidence to the National Crime Agency Pay Review Body the FDA argues for urgent reform of the NCA pay structure.